Biocartis Group NV
Diagnostics & Research
News & analysis
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for the patients, clinicians, payers, and industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.Biocartis Group NV along with its subsidiaries develops proprietary molecular diagnostics platform offering molecular information from any biological sample, enabling fast and effective diagnostics treatment selection and treatment progress monitoring.
Latest BCART News